title: The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
authors.affiliation: Institute of Psychiatry, London, England.
authors.forename: I M
authors.initials: IM
authors.lastname: Marks
authors.forename: A
authors.initials: A
authors.lastname: De Albuquerque
authors.forename: J
authors.initials: J
authors.lastname: Cottraux
authors.forename: V
authors.initials: V
authors.lastname: Gentil
authors.forename: J
authors.initials: J
authors.lastname: Greist
authors.forename: I
authors.initials: I
authors.lastname: Hand
authors.forename: R L
authors.initials: RL
authors.lastname: Liberman
authors.forename: J S
authors.initials: JS
authors.lastname: Relvas
authors.forename: A
authors.initials: A
authors.lastname: Tobeña
authors.forename: P
authors.initials: P
authors.lastname: Tyrer
mesh_terms: D000379:Agoraphobia / Q000188:drug therapy / Q000523:psychology; D000525:Alprazolam / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005239:Fear; D006801:Humans; D010043:Outcome and Process Assessment, Health Care; D010200:Panic; D010352:Patient Dropouts; D010919:Placebos; D019966:Substance-Related Disorders / Q000209:etiology
chemical_list: D010919:Placebos; D000525:Alprazolam